How can fluoxetine affect the active metabolite levels of tetrabenazine?

Fluoxetine inhibits CYP2D6 and may increase plasma concentrations of tetrabenazine’s active metabolite dihydrotetrabenazine, so the combination requires caution and a tetrabenazine dose reduction may be necessary.